Role of toll-like receptors in myocardial infarction

References

• Chao W. Toll-like receptor signaling: a critical modulator of cell survival and ischemic injury in the heart. Am J Physiol Heart Circ Physiol 2009;296:H1–12
   PubMed Web of Science ®Google Scholar
• Korla K, Arrigo P, Mitra CK. Promoters, toll like receptors and microRNAs: a strange association. Indian J Biochem Biophys 2013;50:169–76
   PubMed Web of Science ®Google Scholar
• Slawinska A, D'Andrea M, Pilla F, et al. Expression profiles of Toll-like receptors 1, 2 and 5 in selected organs of commercial and indigenous chickens. J Appl Genet 2013;54:489–92
   Google Scholar
• Kortylewski M, Pal SK. The dark side of Toll-like receptor signaling: TLR9 activation limits the efficacy cancer radiotherapy. Oncoimmunology 2014;3:e27894
   PubMed Web of Science ®Google Scholar
• Liu J, Buisman-Pijlman F, Hutchinson MR. Toll-like receptor 4: innate immune regulator of neuroimmune and neuroendocrine interactions in stress and major depressive disorder. Front Neurosci 2014;8:309
   PubMed Web of Science ®Google Scholar
• Ma FJ, Liu ZB, Hu X, et al. Prognostic Value of Myeloid Differentiation Primary Response 88 and Toll-Like Receptor 4 in Breast Cancer Patients. PLoS One 2014;9:e111639
   PubMed Web of Science ®Google Scholar
• Tian L, Zhou DS, Wang KZ, et al. Association of toll-like receptor 4 signaling pathway with steroid-induced femoral head osteonecrosis in rats. J Huazhong Univ Sci Technolog Med Sci 2014;34:679–86
   PubMed Web of Science ®Google Scholar
• Zhang X, Cowan BR, Bluemke DA, et al. Atlas-Based Quantification of Cardiac Remodeling Due to Myocardial Infarction. PLoS One 2014;9:e110243
   PubMed Web of Science ®Google Scholar
• Bowen TS, Mangner N, Werner S, et al. Diaphragm muscle weakness in mice is early-onset post myocardial infarction and associated with elevated protein oxidation. J Appl Physiol (1985) 2014. (Epub ahead of print)
   Google Scholar
• Arslan F, Smeets MB, O'Neill LA, et al. Myocardial ischemia/reperfusion injury is mediated by leukocytic toll-like receptor-2 and reduced by systemic administration of a novel anti-toll-like receptor-2 antibody. Circulation 2010;121:80–90
   PubMed Web of Science ®Google Scholar
• Mersmann J, Berkels R, Zacharowski P, et al. Preconditioning by toll-like receptor 2 agonist Pam3CSK4 reduces CXCL1-dependent leukocyte recruitment in murine myocardial ischemia/reperfusion injury. Crit Care Med 2010;38:903–9
   PubMed Web of Science ®Google Scholar
• Shishido T, Nozaki N, Yamaguchi S, et al. Toll-like receptor-2 modulates ventricular remodeling after myocardial infarction. Circulation 2003;108:2905–10
   PubMed Web of Science ®Google Scholar
• Ha T, Hu Y, Liu L, et al. TLR2 ligands induce cardioprotection against ischaemia/reperfusion injury through a PI3K/Akt-dependent mechanism. Cardiovasc Res 2010;87:694–703
   PubMed Web of Science ®Google Scholar
• Ueland T, Espevik T, Kjekshus J, et al. Mannose binding lectin and soluble Toll-like receptor 2 in heart failure following acute myocardial infarction. J Card Fail 2006;12:659–63
   PubMed Web of Science ®Google Scholar
• Chen C, Feng Y, Zou L, et al. Role of extracellular RNA and TLR3-Trif signaling in myocardial ischemia-reperfusion injury. J Am Heart Assoc 2014;3:e000683
   PubMed Web of Science ®Google Scholar
• Yang J, Jin LY, Ding JW, et al. Expression of Toll-like receptor 4 on peripheral blood mononuclear cells and its effects on patients with acute myocardial infarction treated with thrombolysis. Arch Med Res 2010;41:423–9
   PubMed Web of Science ®Google Scholar
• Sheng FQ, Xu R, Cheng LX, et al. In rats with myocardial infarction, interference by simvastatin with the TLR4 signal pathway attenuates ventricular remodelling. Acta Cardiol 2009;64:779–85
   PubMed Web of Science ®Google Scholar
• Kashiwagi M, Imanishi T, Ozaki Y, et al. Differential expression of Toll-like receptor 4 and human monocyte subsets in acute myocardial infarction. Atherosclerosis 2012;221:249–53
   PubMed Web of Science ®Google Scholar
• Liu CC, Huang Y, Zhang JH, et al. Effect of carvedilol on cardiac dysfunction 4 days after myocardial infarction in rats: role of toll-like receptor 4 and beta-arrestin 2. Eur Rev Med Pharmacol Sci 2013;17:2103–10
   PubMed Web of Science ®Google Scholar
• Oyama J, Blais C, Jr Liu X, et al. Reduced myocardial ischemia-reperfusion injury in toll-like receptor 4-deficient mice. Circulation 2004;109:784–9
   PubMed Web of Science ®Google Scholar
• Zhao P, Wang J, He L, et al. Deficiency in TLR4 signal transduction ameliorates cardiac injury and cardiomyocyte contractile dysfunction during ischemia. J Cell Mol Med 2009;13:1513–25
   PubMed Web of Science ®Google Scholar
• Chong AJ, Shimamoto A, Hampton CR, et al. Toll-like receptor 4 mediates ischemia/reperfusion injury of the heart. J Thorac Cardiovasc Surg 2004;128:170–9
   PubMed Web of Science ®Google Scholar
• Holloway JW, Yang IA, Ye S. Variation in the toll–like receptor 4 gene and susceptibility to myocardial infarction. Pharmacogenet Genomics 2005;15:15–21
   PubMedGoogle Scholar
• Edfeldt K, Bennet AM, Eriksson P, et al. Association of hypo-responsive toll-like receptor 4 variants with risk of myocardial infarction. Eur Heart J 2004;25:1447–53
   PubMed Web of Science ®Google Scholar
• Hernesniemi J, Lehtimaki T, Rontu R, et al. Toll-like receptor 4 polymorphism is associated with coronary stenosis but not with the occurrence of acute or old myocardial infarctions. Scand J Clin Lab Invest 2006;66:667–75
   PubMed Web of Science ®Google Scholar
• Koch W, Hoppmann P, Pfeufer A, et al. Toll-like receptor 4 gene polymorphisms and myocardial infarction: no association in a Caucasian population. Eur Heart J 2006;27:2524–9
   PubMed Web of Science ®Google Scholar
• Yin YW, Sun QQ, Hu AM, et al. Toll-like receptor 4 gene Asp299Gly polymorphism in myocardial infarction: a meta-analysis of 15,148 subjects. Hum Immunol 2014;75:163–9
   PubMed Web of Science ®Google Scholar
• Satoh M, Shimoda Y, Maesawa C, et al. Activated toll-like receptor 4 in monocytes is associated with heart failure after acute myocardial infarction. Int J Cardiol 2006;109:226–34
   PubMed Web of Science ®Google Scholar
• Shimamoto A, Chong AJ, Yada M, et al. Inhibition of Toll-like receptor 4 with eritoran attenuates myocardial ischemia-reperfusion injury. Circulation 2006;114:I270–4
   PubMed Web of Science ®Google Scholar
• Stapel H, Kim SC, Osterkamp S, et al. Toll-like receptor 4 modulates myocardial ischaemia-reperfusion injury: role of matrix metalloproteinases. Eur J Heart Fail 2006;8:665–72
   PubMed Web of Science ®Google Scholar
• Riad A, Jager S, Sobirey M, et al. Toll-like receptor-4 modulates survival by induction of left ventricular remodeling after myocardial infarction in mice. J Immunol 2008;180:6954–61
   PubMed Web of Science ®Google Scholar
• Timmers L, Sluijter JP, van Keulen JK, et al. Toll-like receptor 4 mediates maladaptive left ventricular remodeling and impairs cardiac function after myocardial infarction. Circ Res 2008;102:257–64
   PubMed Web of Science ®Google Scholar
• Sheu JJ, Chang LT, Chiang CH, et al. Prognostic value of activated toll-like receptor-4 in monocytes following acute myocardial infarction. Int Heart J 2008;49:1–11
   PubMed Web of Science ®Google Scholar
• Ishikawa Y, Satoh M, Itoh T, et al. Local expression of Toll-like receptor 4 at the site of ruptured plaques in patients with acute myocardial infarction. Clin Sci (Lond) 2008;115:133–40
   PubMed Web of Science ®Google Scholar
• Mathur S, Walley KR, Boyd JH. The Toll-like receptor 9 ligand CPG-C attenuates acute inflammatory cardiac dysfunction. Shock 2011;36:478–83
   PubMed Web of Science ®Google Scholar
• Zhou TB. Signaling pathways of PAX2 and its role in renal interstitial fibrosis and glomerulosclerosis. J Recept Signal Transduct Res 2012;32:298–303
   PubMed Web of Science ®Google Scholar
• Zhou TB. Signaling pathways of apoE and its role of gene expression in glomerulus diseases. J Recept Signal Transduct Res 2013;33:73–8
   PubMed Web of Science ®Google Scholar
• Zhou TB, Qin YH. The signaling pathways of LMX1B and its role in glomerulosclerosis. J Recept Signal Transduct Res 2012;32:285–9
   PubMed Web of Science ®Google Scholar
• Zhou TB, Qin YH. Signaling pathways of prohibitin and its role in diseases. J Recept Signal Transduct Res 2013;33:28–36
   PubMed Web of Science ®Google Scholar